prochlorperazine edisylate

Generic: prochlorperazine edisylate

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name prochlorperazine edisylate
Generic Name prochlorperazine edisylate
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION
Routes
INTRAMUSCULAR INTRAVENOUS
Active Ingredients

prochlorperazine edisylate 5 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1558
Product ID 51662-1558_10358f91-4227-7e42-e063-6394a90a62de
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA089903
Listing Expiration 2026-12-31
Marketing Start 2022-06-15

Pharmacologic Class

Classes
phenothiazine [epc] phenothiazines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621558
Hyphenated Format 51662-1558

Supplemental Identifiers

RxCUI
2102949
UPC
0323155294316
UNII
PG20W5VQZS

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name prochlorperazine edisylate (source: ndc)
Generic Name prochlorperazine edisylate (source: ndc)
Application Number ANDA089903 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 5 mg/mL
source: ndc
Packaging
  • 25 POUCH in 1 CASE (51662-1558-3) / 1 VIAL in 1 POUCH (51662-1558-2) / 2 mL in 1 VIAL
source: ndc

Packages (1)

51662-1558-3 25 POUCH in 1 CASE (51662-1558-3) / 1 VIAL in 1 POUCH (51662-1558-2) / 2 mL in 1 VIAL

Ingredients (1)

prochlorperazine edisylate (5 mg/mL)

Linked Drug Pages (1)

PROCHLORPERAZINE EDISYLATE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "10358f91-4227-7e42-e063-6394a90a62de", "openfda": {"upc": ["0323155294316"], "unii": ["PG20W5VQZS"], "rxcui": ["2102949"], "spl_set_id": ["e181c18d-32a8-587e-e053-2995a90acc5b"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "25 POUCH in 1 CASE (51662-1558-3)  / 1 VIAL in 1 POUCH (51662-1558-2)  / 2 mL in 1 VIAL", "package_ndc": "51662-1558-3", "marketing_start_date": "20220615"}], "brand_name": "PROCHLORPERAZINE EDISYLATE", "product_id": "51662-1558_10358f91-4227-7e42-e063-6394a90a62de", "dosage_form": "INJECTION", "pharm_class": ["Phenothiazine [EPC]", "Phenothiazines [CS]"], "product_ndc": "51662-1558", "generic_name": "PROCHLORPERAZINE EDISYLATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PROCHLORPERAZINE EDISYLATE", "active_ingredients": [{"name": "PROCHLORPERAZINE EDISYLATE", "strength": "5 mg/mL"}], "application_number": "ANDA089903", "marketing_category": "ANDA", "marketing_start_date": "20220615", "listing_expiration_date": "20261231"}